Compare

Two terms, side by side

Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

Investment & Finance

Initial Public Offering(IPO)

In one line

First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.

Definition

An Initial Public Offering (IPO) is the first sale of a company's equity to public investors through a registered offering filed with the SEC under the Securities Act of 1933 (Form S-1). The process includes pre-filing organizational meetings, drafting the S-1 prospectus, SEC review, the road show, pricing, and listing on a national exchange (NYSE, Nasdaq). MedTech IPO windows are highly cyclical and typically require either commercial-stage revenue or late-stage clinical data with a near-term FDA decision.

Why it matters

For MedTech, the IPO is one of two primary liquidity paths (the other is M&A). Public-company readiness imposes ongoing 10-K, 10-Q, 8-K, SOX 404, and Reg FD obligations that materially change operating cost.

Common pitfalls

•Going public too early — public markets punish missed clinical or commercial milestones harshly.
•Underestimating SOX 404(b) internal-control audit costs in the first post-IPO year.

Sources

SEC — Form S-1 · SEC
SEC — Going Public · SEC
Silicon Valley Bank - Healthcare Reports · SVB

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.